{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:53:37Z","timestamp":1791374017345,"version":"4.3.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.idnow.2025.105122","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T23:12:54Z","timestamp":1753485174000},"page":"105122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Amoxicillin\/clavulanate activity against bacteria isolated in severe community-acquired pneumonia: a retrospective study (sCAP)"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1793-9295","authenticated-orcid":false,"given":"A.","family":"Sarr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9609-8246","authenticated-orcid":false,"given":"M.A.","family":"Matta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Kayembe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8371-2537","authenticated-orcid":false,"given":"A.","family":"Depontfarcy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Monchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Diamantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.idnow.2025.105122_b0005","first-page":"E3463","article-title":"Global increase in antibiotic consumption","volume":"115","author":"Klein","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"10.1016\/j.idnow.2025.105122_b0010","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","article-title":"Hydrocortisone in Severe CAP","volume":"388","author":"Dequin","year":"2023","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.idnow.2025.105122_b0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/bjaed\/mkv052","article-title":"Severe community-acquired pneumonia","volume":"16","author":"Morgan","year":"2016","journal-title":"BJA Educ"},{"issue":"166","key":"10.1016\/j.idnow.2025.105122_b0020","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0150-2022","article-title":"Respiratory infections","volume":"31","author":"Niederman","year":"2022","journal-title":"Eur Respir Rev"},{"issue":"7","key":"10.1016\/j.idnow.2025.105122_b0025","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of CAP","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.idnow.2025.105122_b0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12879-015-0933-9","article-title":"Spectrum score method","volume":"15","author":"Madaras-Kelly","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.idnow.2025.105122_b0035","unstructured":"World Health Organization [Internet]. 2021. WHO AWaRe classification of antibiotics for evaluation and monitoring of use. 2021 [cited April 30, 2025]. Available from: https:\/\/iris.who.int\/handle\/10665\/345555."},{"key":"10.1016\/j.idnow.2025.105122_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107663","article-title":"Updates on community acquired pneumonia management in the ICU","volume":"217","author":"Nair","year":"2021","journal-title":"Pharmacol Ther"},{"issue":"Suppl 2","key":"10.1016\/j.idnow.2025.105122_b0045","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"IDSA\/ATS guidelines","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2025.105122_b0050","unstructured":"Legifrance [Internet]. Article 1 - Loi n\u00b0 2012-300 du 5 mars 2012 relative aux recherches impliquant la personne humaine [cited April 30, 2025]. Available from: https:\/\/www.legifrance.gouv.fr\/jorf\/article_jo\/JORFARTI000025441588."},{"issue":"1","key":"10.1016\/j.idnow.2025.105122_b0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.therap.2016.12.006","article-title":"French Jard\u00e9\u2019s law","volume":"72","author":"Deplanque","year":"2017","journal-title":"Therapies"},{"key":"10.1016\/j.idnow.2025.105122_b0060","unstructured":"The European Committee on Antimicrobial Susceptibility Testing [Internet]. Breakpoint tables for interpretation of MICs and zone diameters, Version 11.0. 2021 [cited April 30, 2025]. Available from: https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_11.0_Breakpoint_Tables.pdf."},{"issue":"8","key":"10.1016\/j.idnow.2025.105122_b0065","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.idnow.2025.105122_b0070","unstructured":"Sant\u00e9 publique France [Internet]. 2025. Surveillance de la r\u00e9sistance bact\u00e9rienne aux antibiotiques en soins de ville et en \u00e9tablissements pour personnes \u00e2g\u00e9es d\u00e9pendantes. Mission Primo : r\u00e9sultats 2023 [cited July 23, 2025]. Available from: https:\/\/www.santepubliquefrance.fr\/import\/surveillance-de-la-resistance-bacterienne-aux-antibiotiques-en-soins-de-ville-et-en-etablissements-pour-personnes-agees-dependantes.-mission-primo."},{"issue":"6","key":"10.1016\/j.idnow.2025.105122_b0075","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/cid\/ciy1031","article-title":"Empiric antibiotic thresholds","volume":"69","author":"Cressman","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idnow.2025.105122_b0080","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.cmi.2018.06.021","article-title":"AMC vs 3GC in pneumonia","volume":"24","author":"Batard","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.idnow.2025.105122_b0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13613-017-0259-4","article-title":"AMC in ICU CAP","volume":"7","author":"Hariri","year":"2017","journal-title":"Ann Intensive Care"},{"issue":"2","key":"10.1016\/j.idnow.2025.105122_b0090","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/jac\/dks406","article-title":"Antibiotics and resistance","volume":"68","author":"Gbaguidi-Haore","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"2 Suppl","key":"10.1016\/j.idnow.2025.105122_b0095","doi-asserted-by":"crossref","first-page":"426S","DOI":"10.1378\/chest.119.2_suppl.426S","article-title":"Antibiotic utilization and resistance","volume":"119","author":"Patterson","year":"2001","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.idnow.2025.105122_b0100","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1089\/mdr.2017.0360","article-title":"AMC and resistance","volume":"24","author":"Marquet","year":"2018","journal-title":"Microb Drug Resist"},{"issue":"4","key":"10.1016\/j.idnow.2025.105122_b0105","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00735-2022","article-title":"ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia","volume":"61","author":"Martin-Loeches","year":"2023","journal-title":"Eur Respir J"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991925001010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991925001010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:18:30Z","timestamp":1791371910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991925001010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2666991925001010"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2025.105122","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amoxicillin\/clavulanate activity against bacteria isolated in severe community-acquired pneumonia: a retrospective study (sCAP)","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2025.105122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105122"}}